Insider trades
Bios Fund III, Director of Actuate Therapeutics ACTU, has filed 9 purchases and 9 sales on the open market. The latest trade was on 25/06/27.
Bios Fund III
Director
- Company
- Actuate Therapeutics ACTU
- First filing
- 23/06/13
- Trades
- 110 trades
- Buys / sales
- 9 / 9
- 12-month net buying
- No record
- Last trade
- 25/06/27
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/06/27 | 25/06/30 | 71,428 sh | $7.00 | $499,996 | +57.1% | |
ACTU | Open-market saleAmendment | 24/08/14 | 24/08/20 | 24,999 sh3 trades | $8.00avg. | $199,992 | −16.0% |
ACTU | Open-market buy | 24/08/14 | 24/08/14 | 500,000 sh2 trades | $8.00avg. | $4,000,000 | No record |
ACTU | Open-market sale | 24/08/14 | 24/08/14 | 24,999 sh3 trades | $9.00avg. | $224,991 | −16.0% |
AZTR | Open-market buy | 23/06/21 | 23/06/23 | 2,297,490 sh6 trades | No stated value | No stated value | No record |
AZTR | Open-market sale | 23/06/21 | 23/06/23 | 669,317 sh3 trades | No stated value | No stated value | −100.0% |
